Found: 8
Select item for more details and to access through your institution.
Therapie der Psoriasis mit Fumarsäureestern (Fumaderm<sup>®</sup>).
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2007, v. 5, n. 8, p. -1, doi. 10.1111/j.1610-0387.2007.06346_supp.x
- By:
- Publication type:
- Article
Treatment of psoriasis with fumaric acid esters (Fumaderm<sup>®</sup>).
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2007, v. 5, n. 8, p. 716, doi. 10.1111/j.1610-0387.2007.06346.x
- By:
- Publication type:
- Article
A Highly Decreased Binding of Cyclic Adenosine Monophosphate to Protein Kinase A in Erythrocyte Membranes is Specific for Active Psoriasis.
- Published in:
- Journal of Investigative Dermatology, 2002, v. 119, n. 1, p. 160, doi. 10.1046/j.1523-1747.2002.01808.x
- By:
- Publication type:
- Article
TNF<sub>α</sub> Primes Polymorphonuclear Leukocytes for an Enhanced Respiratory Burst to a Similar Extent As Bacterial Lipopolysaccharide.
- Published in:
- Journal of Investigative Dermatology, 1990, v. 95, p. 216S, doi. 10.1111/1523-1747.ep12875802
- By:
- Publication type:
- Article
Stimulus-Dependent Increased Generation of Oxygen Intermediates in Monocytes and Polymorphonuclear Leukocytes in Psoriasis.
- Published in:
- Journal of Investigative Dermatology, 1985, v. 84, n. 1, p. 73, doi. 10.1111/1523-1747.ep12274844
- By:
- Publication type:
- Article
Galenic concept of supersaturation may improve the cutaneous absorption of calcipotriol plus betamethasone dipropionate aerosol foam compared with other topical formulations.
- Published in:
- JEADV Clinical Practice, 2024, v. 3, n. 1, p. 328, doi. 10.1002/jvc2.316
- By:
- Publication type:
- Article
PPMS onset upon adalimumab treatment extends the spectrum of anti-TNF-α therapy-associated demyelinating disorders.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286419895155
- By:
- Publication type:
- Article
PPMS onset upon adalimumab treatment extends the spectrum of anti-TNF-α therapy-associated demyelinating disorders.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286419895155
- By:
- Publication type:
- Article